California § 14105.435. 14105.435. (Added by Stats. 1992, Ch. 949, Sec. 2.)

California Statutes

§ 14105.435. — 14105.435. (Added by Stats. 1992, Ch. 949, Sec. 2.)

California § 14105.435.

JurisdictionCalifornia

Code WICWelfare and Institutions Code - WIC

Div. 9.DIVISION 9. PUBLIC SOCIAL SERVICES

Part 3.PART 3. AID AND MEDICAL ASSISTANCE

Ch. 7.CHAPTER 7. Basic Health Care

Art. 3.ARTICLE 3. Administration

This text of California § 14105.435. (14105.435. (Added by Stats. 1992, Ch. 949, Sec. 2.)) is published on Counsel Stack Legal Research, covering California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Cal. Welfare and Institutions Code - WIC Code § 14105.435. (2026).

Text

(a)Within 60 days of the approval of a drug in accordance with subdivision (a) of Section 14105.43, the department shall assign to that drug a reimbursement code, and provide notice to providers that the drug is on the Medi-Cal list of contract drugs.

(b)In the event that a manufacturer has not notified the department in writing of the approval of a drug by the United States Food and Drug Administration for the treatment of acquired immune deficiency syndrome (AIDS) or an AIDS-related condition within 15 days of that approval, the department shall be granted an additional 30 days to comply with subdivision (a). Written notification from the drug manufacturer shall include a copy of the United States Food and Drug Administration approval letter and the official labeling for the drug

Free access — add to your briefcase to read the full text and ask questions with AI

(a)
Within 60 days of the approval of a drug in accordance with subdivision (a) of Section 14105.43, the department shall assign to that drug a reimbursement code, and provide notice to providers that the drug is on the Medi-Cal list of contract drugs.
(b)
In the event that a manufacturer has not notified the department in writing of the approval of a drug by the United States Food and Drug Administration for the treatment of acquired immune deficiency syndrome (AIDS) or an
AIDS-related condition within 15 days of that approval, the department shall be granted an additional 30 days to comply with subdivision (a). Written notification from the drug manufacturer shall include a copy of the United States Food and Drug Administration approval letter and the official labeling for the drug.